Jia Jie Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	240.83	296.47	112.94	354.42	125.53	172.28
Short-Term Investments	181.06	104.06	62.06	29.74	128.21	114.03
Trading Asset Securities	78.44	81.03	88.05	-	-	-
Cash & Short-Term Investments	500.33	481.56	263.05	384.17	253.75	286.31
Cash Growth	-8.30%	83.07%	-31.53%	51.40%	-11.37%	-16.81%
Accounts Receivable	50.77	49.5	48.06	17.77	16.21	21.06
Other Receivables	1.69	1.83	1.85	2.82	2.78	3.38
Receivables	52.47	51.33	49.91	20.59	18.98	24.43
Inventory	29.66	27.68	24.49	24.68	26.64	20.8
Prepaid Expenses	6.61	10.8	7.98	4.99	17.23	8.65
Other Current Assets	3.19	3.12	2.91	2.89	0.61	0.1
Total Current Assets	592.26	574.48	348.34	437.31	317.21	340.28
Property, Plant & Equipment	489.8	491.8	450.75	448.81	451.21	444.91
Long-Term Investments	573.99	598.43	493.13	402.86	112.83	112.63
Goodwill	71.86	71.86	71.86	19.78	19.78	19.78
Other Intangible Assets	1.97	2.31	3.69	0.4	0.46	0.5
Long-Term Accounts Receivable	6	5.15	5.4	6.72	7.4	2.16
Long-Term Deferred Tax Assets	47.95	50.92	46.95	49.94	47.45	48.48
Other Long-Term Assets	95.41	93.94	62.18	47.11	47.62	52.66
Total Assets	1,879	1,889	1,482	1,413	1,004	1,021

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	23.75	24.46	12.46	11.27	10.3	11.72
Accrued Expenses	52.59	59.04	72.18	67.9	47.99	53.54
Short-Term Debt	20	50	-	237.45	-	-
Current Portion of Long-Term Debt	4.38	-	-	-	-	-
Current Portion of Leases	1.7	2.43	2.46	0.81	2.53	2.29
Current Income Taxes Payable	2.99	6.61	5.28	1.57	0.38	0.91
Current Unearned Revenue	0.36	0.82	0.38	0.53	0.36	0.85
Other Current Liabilities	47.27	27.48	24.1	17.31	11.97	12.63
Total Current Liabilities	153.05	170.84	116.85	336.84	73.52	81.93
Long-Term Debt	69.82	3.61	4.03	4.7	5.18	1.51
Long-Term Leases	0.53	0.24	1.99	0.94	1.09	2.82
Other Long-Term Liabilities	0.21	0.21	0.21	0.21	0.21	0.21
Total Liabilities	223.6	174.89	123.08	342.69	80	86.47

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1,187	1,187	987.37	889.37	889.37	889.37
Additional Paid-In Capital	251.84	251.58	91.05	58.3	57.01	57.01
Retained Earnings	282.58	340.72	349.83	163.02	18.87	24.28
Comprehensive Income & Other	-96.84	-95.86	-97.23	-63.82	-67.27	-62.79
Total Common Equity	1,625	1,684	1,331	1,047	897.98	907.87
Minority Interest	30.68	30.19	28.19	23.35	25.99	27.05
Shareholders' Equity	1,656	1,714	1,359	1,070	923.96	934.92
Total Liabilities & Equity	1,879	1,889	1,482	1,413	1,004	1,021

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	96.42	56.27	8.48	243.9	8.8	6.61
Net Cash (Debt)	403.91	425.29	254.57	140.26	244.95	279.69
Net Cash Growth	-24.89%	67.06%	81.49%	-42.74%	-12.42%	-17.73%
Net Cash Per Share	3.40	3.65	2.59	1.57	2.75	3.14
Filing Date Shares Outstanding	118.74	118.74	98.74	88.94	88.94	88.94
Total Common Shares Outstanding	118.74	118.74	98.74	88.94	88.94	88.94
Working Capital	439.21	403.64	231.49	100.47	243.7	258.36
Book Value Per Share	13.69	14.18	13.48	11.77	10.10	10.21
Tangible Book Value	1,551	1,610	1,255	1,027	877.74	887.59
Tangible Book Value Per Share	13.06	13.56	12.72	11.54	9.87	9.98
Land	178.91	178.91	178.91	178.91	178.55	171.76
Buildings	400.52	400.52	380.85	382.81	380.89	376.79
Machinery	134.62	127.86	92.92	78.21	92.18	86.21